Embecta (EMBC) Non Operating Income (2021 - 2026)
Embecta (EMBC) posted Non Operating Income of -$22.6 million for Q1 2026, up 6.22% sequentially from -$24.1 million in Q4 2025, and up 15.36% YoY from -$19.6 million in Q1 2025.
Embecta (EMBC) Non Operating Income (2021 - 2026) Analysis & Trends
Embecta has reported Non Operating Income for 6 years, with the latest figure at -$22.6 million in Q1 2026.
- Quarterly Non Operating Income rose 15.36% year-over-year to -$22.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.8 million (down 6.64% YoY) and the FY2025 annual result came in at $1.5 million, up 114.56% from the prior year.
- Non Operating Income climbed to -$22.6 million in Q1 2026 per EMBC's latest filing, from -$24.1 million in the prior quarter.
- Over five years, Non Operating Income peaked at $82.7 million in Q3 2025 and troughed at -$27.7 million in Q4 2023.
- A 5-year average of $3.8 million and a median of -$2.7 million in 2022 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 2714.81% in 2023, down 4200.0% in 2023.
- Over 5 years, Non Operating Income stood at -$7.1 million in 2022, then sank by 290.14% to -$27.7 million in 2023, then surged by 94.58% to -$1.5 million in 2024, then sank by 1506.67% to -$24.1 million in 2025, then advanced by 6.22% to -$22.6 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$22.6 million, -$24.1 million, and $82.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.90 Mn |
| Mar 31, 2026 | -22.60 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | 82.70 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | -26.70 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 73.00 Mn |
| Jun 30, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | -4.30 Mn |
| Dec 31, 2022 | -7.10 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -19.50 Mn |
| Mar 31, 2022 | -100,000.00 |
| Sep 30, 2021 | -3.70 Mn |
| Jun 30, 2021 | 600,000.00 |